title: Are OKT3 binding sites on T cells modulated or merely converted (blindfolded) by OKT3 during therapy?
authors.affiliation: Department of Surgery, University of Miami School of Medicine, Florida 33101.
authors.forename: M
authors.initials: M
authors.lastname: Carreno
authors.forename: J
authors.initials: J
authors.lastname: Miller
authors.forename: V
authors.initials: V
authors.lastname: Esquenazi
authors.forename: M
authors.initials: M
authors.lastname: Milgrom
authors.forename: D
authors.initials: D
authors.lastname: Roth
authors.forename: L
authors.initials: L
authors.lastname: Fuller
mesh_terms: D000911:Antibodies, Monoclonal / Q000032:analysis / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology; D018801:CD2 Antigens; D017252:CD3 Complex; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology; D011863:Radioimmunoassay; D011948:Receptors, Antigen, T-Cell / Q000032:analysis / Q000276:immunology*; D011971:Receptors, Immunologic / Q000032:analysis / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D018801:CD2 Antigens; D017252:CD3 Complex; D011948:Receptors, Antigen, T-Cell; D011971:Receptors, Immunologic